Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 5 | 1 | — | — | — | 5 |
Colorectal neoplasms | D015179 | — | — | 2 | 1 | — | — | — | 2 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 1 | — | — | — | 2 |
Neurofibromatosis 1 | D009456 | — | Q85.01 | — | 2 | — | — | — | 2 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 2 | — | — | — | 2 |
Plexiform neurofibroma | D018318 | EFO_0000658 | — | — | 1 | — | — | — | 1 |
Melanoma | D008545 | — | — | 1 | 1 | — | — | — | 1 |
Colonic neoplasms | D003110 | — | C18 | 1 | 1 | — | — | — | 1 |
Triple negative breast neoplasms | D064726 | — | — | 1 | 1 | — | — | — | 1 |
Vascular malformations | D054079 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | — | — | — | — | 1 | 1 |
Drug common name | MIRDAMETINIB |
INN | mirdametinib |
Description | PD 0325901 is a hydroxamic acid ester that is benzhydroxamic acid (N-hydroxybenzamide) in which the hydroxamic acid group has been converted to the corresponding 2,3-dihydroxypropyl ester and in which the benzene ring has been substituted at position 2 by a (2-fluoro-4-iodophenyl)amino group and at positions 3 and 4 by fluorines (the R enantiomer). It has a role as an EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor and an antineoplastic agent. It is a hydroxamic acid ester, a secondary amino compound, a member of monofluorobenzenes, an organoiodine compound, a member of propane-1,2-diols and a difluorobenzene. |
Classification | Small molecule |
Drug class | tyrosine kinase inhibitors: tyrosine kinase inhibitors; MEK (MAPK kinase) inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F |
PDB | — |
CAS-ID | 391210-10-9 |
RxCUI | — |
ChEMBL ID | CHEMBL507361 |
ChEBI ID | 88249 |
PubChem CID | 9826528 |
DrugBank | — |
UNII ID | 86K0J5AK6M (ChemIDplus, GSRS) |